Ainos (OTCMKTS:AIMD) Stock Price Down 2.4% – Here’s What Happened

Ainos, Inc. (OTCMKTS:AIMD) shares traded down 2.4% during mid-day trading on Tuesday . The company traded as low as $2.01 and last traded at $2.01. 2,852 shares changed hands during trading, a decline of 100% from the average session volume of 659,060 shares. The stock had previously closed at $2.06.

Ainos Trading Up 1.7%

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.92 and a quick ratio of 1.45. The business’s 50-day simple moving average is $2.65 and its two-hundred day simple moving average is $2.80. The stock has a market capitalization of $9.84 million, a price-to-earnings ratio of -2.35 and a beta of 2.39.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.